Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208673

SOLIQUA 100/33 (INSULIN GLARGINE; LIXISENATIDE)
300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML) Marketing Status: Prescription

Active Ingredient: INSULIN GLARGINE; LIXISENATIDE
Proprietary Name: SOLIQUA 100/33
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208673
Product Number: 001
Approval Date: Nov 21, 2016
Applicant Holder Full Name: SANOFI-AVENTIS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English